GlaxoSmithKline PLC (LSE:GSK) - Share price


Stock Report

GlaxoSmithKline PLC GSK

Directors' Share Dealings
 Transaction Holding 
Director/Date/TypeAmountPrice (GBX)Value (£) Amount% Additional Info
Ms. Lynn Laverty Elsenhans
29/07/2020 | Purchase
1,30120.4126,553.00 41,886< 0.001 ADRs
Ms. Judy C. Lewent
29/07/2020 | Purchase
80820.4116,491.00 29,451< 0.001 ADRs
Dr. Laurie H. Glimcher, M.D.
29/07/2020 | Purchase
2,44520.4149,902.00 17,874< 0.001 ADRs
Mr. Jonathan Richard Symonds CBE
29/07/2020 | Purchase
2,7531,589.0043,745.00 38,311< 0.001 As advised by the company
Mr. Manvinder Singh Banga
29/07/2020 | Purchase
5701,589.009,057.00 62,4210.001 As advised by the company
Mr. Urs Rohner
29/07/2020 | Purchase
5311,589.008,438.00 12,129< 0.001 As advised by the company
Dr. Vivienne Cox, CBE
29/07/2020 | Purchase
6881,589.0010,932.00 6,577< 0.001 As advised by the company
Mr. Charles A. Bancroft
29/07/2020 | Purchase
1,00220.4120,451.00 1,0020.00 ADRs
Dr. Jesse Goodman
29/07/2020 | Purchase
76920.4115,695.00 8,464< 0.001 ADRs
Mr. Iain J Mackay
13/07/2020 | D
4261,592.806,785.00 36,173< 0.001 Dividend Reinvestment Plan(DRIP)
Ms. Emma N. Walmsley
13/07/2020 | D
7881,592.8012,551.00 500,0750.010 Dividend Reinvestment Plan(DRIP)
Ms. Emma N. Walmsley
13/07/2020 | D
6311,592.8010,051.00 501,4900.010 Dividend Reinvestment Plan(DRIP)
Ms. Emma N. Walmsley
13/07/2020 | D
7841,592.8012,488.00 500,8590.010 Dividend Reinvestment Plan(DRIP)
Ms. Emma N. Walmsley
10/07/2020 | D
2,0061,577.3331,641.00 499,2870.010 Dividend Reinvestment Plan(DRIP)
Ms. Emma N. Walmsley
09/07/2020 | Purchase
81,610.10129.00 497,2730.010 Partnership
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.